Evidence map›Paper›PMID 23721247›Full record

ArticleMalaria journal2013

Vivax malaria and bacteraemia: a prospective study in Kolkata, India.

Sujit Kumar Bhattacharya, Dipika Sur, Shanta Dutta, Suman Kanungo, R Leon Ochiai, Deok Ryun Kim, Nicholas M Anstey, Lorenz von Seidlein, Jacqueline Deen

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Severe Falciparum and Vivax Malaria on the Thailand-Myanmar Border: A Review of 1503 Cases.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  7. Case Report: Severe Plasmodium vivax Malaria after Splenectomy.The American journal of tropical medicine and hygiene · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Management of relapsing Plasmodium vivax malaria.Expert review of anti-infective therapy · 2016
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Sujit Kumar BhattacharyaSociety for Applied Studies, Kolkata, India.
Dipika Sur
Shanta Dutta
Suman Kanungo
R Leon Ochiai
Deok Ryun Kim
Nicholas M Anstey
Lorenz von Seidlein
Jacqueline Deen
National Institute of Cholera and Enteric Diseases · INCharles Darwin University · AUInternational Vaccine Institute · KRMenzies School of Health Research · AUSociety for Applied Studies · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFalciparum malaria increases the risk for bacteraemia, whereas the relationship between vivax malaria and bacteraemia is not clear. Data from a prospective fever surveillance study in Kolkata, India were reanalysed for the potential association between Plasmodium vivax malaria and bacteraemia.

methodsPatients of all ages presenting with fever of three days or more to a project health outpost were invited to participate. A blood film and blood culture was performed on presentation. Treatment and referral were provided according to national guidelines. The case fraction and incidence of malaria, bacteraemia, and co-infection were calculated.

results3,371 participants were enrolled during a one-year study period, of whom 93/3,371 (2.8%) had malaria (89/93 [95.7%] Plasmodium vivax) and 256 (7.6%) bacteraemia. There were 154 malaria, 423 bacteraemia and 10 P. vivax-bacteremia coinfection episodes per 100,000/year. Among the malaria-bacteraemia co-infections, all were vivax malaria and 5/6 (83%) bacteria isolated were Gram-negative (one S. Typhi, one S. Paratyphi A, three other Gram-negative). Bacteraemia occurred in 6/89 (6.7% [95%CI: 3.1-13.9%]) of P. vivax cases versus 250/3,278 (7.6% [95% CI: 6.7-8.6%]) without Plasmodium infection (p=0.76).

conclusionsWhile an increased risk was not demonstrated, concomitant bacteraemia occurs frequently in vivax malaria in an area with a high background incidence of bacteraemia, and should be considered in cases of vivax malaria with severe manifestations.

Indexed as

AdolescentAdultAgedAged, 80 and overBacteremiaBacteriaBloodChildChild, PreschoolCoinfectionComorbidityFemaleHumansIncidenceIndiaInfant

Identifiers

PMID23721247
PMCPMC3691654
OpenAlexW2156403967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.